Stuart Sharpless retweetledi
Okay so the next Pharma to move next I think is #SVNS . This one was hot for months with multiple excellent news and it hit 0.39p highs recently and even at that price people were suggesting it’s worth much more than 0.39p and arguably it probably is. See all the good news it’s had these past few months and it had a recent placing at 0.30p and now is 0.27p so it’s cheap and 12% below the recent placing price. I think as a trade there is 30% in this. If looking at longer term then much more than 30% but from here 30% rise would put it around 0.35p so that’s the initial target I think. I think this target is conservative and achievable and I know @MylesMcNulty is a big fan of #SVNS and called it spot on from the lows. Now it’s time to bounce having consolidated lately. On positive news this will rise significantly again especially at the moment with the Pharma sector being so hot. As always please DYOR and don’t just buy because I say it’s going to rise but this is my opinion and this is one Pharma that is looking very undervalued at these prices. Tops #SVNS
English
